Effect of WRAD Lens on Axial Growth and Refraction in Low-hyperopic Chinese Children

NCT07682974 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2026-07-06

No results posted yet for this study

Summary

Myopia is one of the most common visual impairments worldwide.This not only poses long-term risks to individual health but also imposes significant medical and economic burdens on society. \[6\] Therefore, delaying the onset of myopia and effectively controlling its progression has become an urgent issue that needs to be addressed.In recent years, a new type of highly aspherical lenslet (HAL) has been proposed. Its optical design includes a refractive correction area in the central region and a peripheral annular area. This annular area can form a "myopic defocus zone", increasing the myopic defocus signal around the retina. Studies have confirmed that this design can effectively slow down the progression of myopia in already myopic children. However, it is currently unclear whether this lens has a preventive effect on children who are not yet myopic but have a risk of developing myopia.

Conditions

  • Hyperopic Astigmatism

Interventions

OTHER

With-the-Rule Astigmatic Defocus Lens

The lens was prescribed with 0.00 diopters

OTHER

With-the-Rule Astigmatic Defocus Lens (Non-plano)

The magnitude of the central optical zone completely corrected their refractive errors under baseline cycloplegia

OTHER

Single Vision

The lenses do not have corrective functions

Sponsors & Collaborators

  • He Eye Specialist Hospital

    collaborator UNKNOWN
  • He Eye Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2029-12-01
Completion
2030-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07682974 on ClinicalTrials.gov